Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

57 results about "Kitasamycin" patented technology

Kitasamycin (INN) is a macrolide antibiotic. It is produced by Streptomyces kitasatoensis. The drug has antimicrobial activity against a wide spectrum of pathogens. There are several generic names of this drug such as- •Kitasamycin (OS: BAN, JAN, USAN) •Kitasamycine (OS: DCF) •C 637 (IS) •Katasamycin (IS) •Leucomycin (IS) •Kitasamycin (PH: JP XV) •Kitasamycin Acetate (OS: JAN) •Leucomycin Acetate (IS) •Kitasamycin Acetate (PH: JP XV) •Kitasamycin Tartrate (OS: JAN) •Leucomycin Tartrate (IS) •Kitasamycin Tartrate (PH: JP XV)

Compound feed premix for pigs and production method thereof

The invention relates to a compound feed premix for pigs and a production method thereof. The formula of the compound feed premixing material comprises the following components of a compound enzyme preparation for the pigs, a compound vitamin premix for the pigs, a compound trace element premix for the pigs, a compound additive premix generated by lysine, an antioxidant, choline chloride and an acidulant, calcium hydrophosphate, rock flour, salt, luctarom, a kitasamycin micro-capsule preparation with the mass concentration of 50%, a colistin sulphate micro-capsule preparation with the mass concentration of 10% and zeolite powder. By adding the compound enzyme preparation, amino acid, compound trace elements and a feed sweetener to the compound feed premix, the utilization rate of the pigs on feed nutrients is enhanced, the production performance is improved, and the discharge of substances such as phosphorous, nitrogen and the like to natural environment through excrements of livestock and poultry is reduced; and meanwhile, the disease resistance of the pigs is strengthened, and the economic benefit of feeders is increased when the compound feed premix is applied to cultivation practice.
Owner:WUXI ZHENGDA POULTRY

Production method of enteric-coated kitasamycin for feed

The invention discloses a production method of enteric-coated kitasamycin for feed, which comprises the following process steps: step one, the preparation of drug-loaded pellets; step two, inner layer sustained-release coating of the drug-loaded pellets, which prolongs the release and acting time of kitasamycin; and steps three, outer layer enteric coating of the drug-loaded pellets, which ensures the release in succus entericus and small or no release in gastric juice. The method has the advantages that the kitasamycin is subjected to pellets pelletizing and 99 percent of the prepared granulums can pass through 24 meshes, so the dust is greatly reduced and the fluidity is increased; the coating of the inner layer sustained-release agent (HPMC) prolongs the release and acting time of the kitasamycin, reduces medication times and reduces the medication cost; and a layer of enteric substance, namely acrylic resin-III is sprayed and coated on the outer layer of particles. The substance protects the kitasamycin which is a weakly alkaline antibiotic from being damaged by gastroc acid in stomach, quickly disintegrates after entering enteric canal and releases the kitasamycin; and then the kitasamycin is absorbed by gastrointestinal mucosa into blood drug to play a role of restraining the reproduction of pathogenic microorganism and preventing diarrhea. Insoluble in the stomach, kitasamycin coating formulations have no pessimal stimulation on the stomach, and cannot result in regurgitation and vomiting. In addition, the sustained-release formulation, namely the kitasamycin prolongs the acting time so the medication times is reduced, the medication cost of farmers is reduced, and the economic benefit is improved.
Owner:WUXI ZHENGDA POULTRY

Monoclonal antibody for kitasamycin residual detection and preparation method and application thereof

The invention discloses a monoclonal antibody for kitasamycin residual detection and a preparation method and application thereof. The monoclonal antibody is secreted by a hybridoma KA / 2A9, which is collected by CCTCC (China Center for Type Culture Collection) and has the collection number of C201184. The preparation method comprises the steps of: (A) coupling hapten kitasamycin with bovine serum albumin so as to obtain an immunogen; (B) coupling hapten kitasamycin with ovalbumin so as to obtain a coating antigen; (C) preparing the monoclonal antibody secreted by the hybridoma KA / 2A9 by using the immunogen; (D) coating a solid phase carrier by using the coating antigen; (E) extracting a sample to be detected by using metaphosphoric acid in the presence of ethanol, carrying out back extraction by using ethyl acetate, blow-drying by using nitrogen gas, and diluting the sample so as to obtain a substance to be detected; and (F) carrying out enzyme-linked immunoassay on the substance to be detected. A kit for kitasamycin residual detection comprises an ELISA (Enzyme-Linked Immunosorbent Assay) plate coated by the coating antigen kitasamycin-AOOA-OVA, a kitasamycin standard solution, a goat anti-mouse IgG (Immunoglobulin G) antibody working solution labeled by a horseradish peroxidase, a concentrated phosphate buffer, a concentrated washing solution, a substrate mixture and a stop solution. The method has the characteristics of simplicity, convenience, rapidness, sensitiveness and accuracy.
Owner:HUAZHONG AGRI UNIV

Preparation method for kitasamycin industrial production strains

InactiveCN105420148AGrowth synchronizationAvoid saving time slotsBacteriaMicroorganism based processesBiotechnologySporeling
The invention discloses a preparation method for kitasamycin industrial production strains, which comprises the main steps: performing plate streaking on an original strain to prepare a single colony; transferring the single colony onto an inclined plane, culturing same for a proper time; then scraping spores on the inclined plane with an inoculation loop, and preparing a freeze-dried strain tube with a vacuum freeze-drying method; preparing a spore suspension by using the freeze-dried strain tube, coating the oblique plane with the spore suspension, culturing the spore suspension for a proper time; then scraping spores on the oblique plane with the inoculation loop to prepare a spore and milk suspension; subpackaging the spore and milk suspension and performing freezing preservation so as to prepare a spore and milk freezing tube; melting the spore and milk freezing tube, and transferring same to a seed culture medium, performing shake culture by bottle shaking for a proper time, and then transferring to a seed tank. The method overcome the defects of poor synchronization of inoculation production of inclined strain production, nonuniform growth cycle of seed bottles and frequency of batch number change. The preparation method disclosed by the invention is simple and convenient to operate, the inoculum age of strains and consistency of quality of seeds are improved, the batch number change of seeds is reduced, and the preparation method is very suitable for kitasamycin industrial production.
Owner:TOPFOND PHARMA CO LTD

High-ration fiber piglet compound feed

InactiveCN104719667AImprove developmentIncrease the absorption surfaceAnimal feeding stuffORIGANUM OILStress syndrome
The invention relates to high-ration fiber piglet compound feed. The high-ration fiber piglet compound feed consists of the following ingredients in parts by weight: 250 to 400 parts of corns, 250 to 350 parts of wheat, 80 to 150 parts of extracted soybean meal, 50 to 75 parts of fermented soybean meal, 50 to 100 parts of extruded soybeans, 30 to 100 parts of brown rice, 30 to 60 parts of 65% fish meal, 30 to 70 parts of whey powder, 20 to 80 parts of flour, 10 to 20 parts of soybean oil, 5 to 10 parts of calcium hydrogen phosphate, 5 to 10 parts of stone powder, 4 to 5 parts of piglet micro-mineral premixed material, 5 to 10 parts of citric acid, 3 to 6 parts of 99% lysine, 3 to 5 parts of sodium chloride, 1 to 2 parts of 50% choline chloride, 1 to 2 parts of methionine, 1 to 2 parts of threonine, 4 to 5 parts of self-compounding multi-dimensional premixed material, 0.3 to 0.6 part of tryptophan, 0.3 to 0.5 part of an antioxidant, 0.5 to 0.7 part of origanum oil, 0.05 to 0.1 part of 50% kitasamycin and 0.15 to 0.2 part of colistin sulfate. The ratio of soluble ration fiber to insoluble fiber in the ration is adjusted, so that the weanling stress syndrome of the piglet can be controlled, the intestine health of the piglet can be improved, the diarrhea is reduced, the dependence of the piglet on the antibiotics and the pharmaceutical dose zinc oxide can be alleviated, and the effect is remarkable.
Owner:HUNAN LIUYANGHE FEED

Production method for kitasamycin solid micro-capsules for feed

The invention discloses a production method for kitasamycin solid micro-capsules for feed. The method comprises the following steps that 1, kitasamycin, plastic materials and a solvent are mixed to form pill cores; 2, the pill cores are wrapped by an inner enteric coating layer and an outer enteric coating layer; the inner enteric coating layer and the outer enteric coating layer are formed by mixing inner enteric coating layer materials with the solvent and mixing outer enteric coating layer materials with the solvent respectively, and then the pill cores are sequentially wrapped to form granules. According to the method, the phenomenon that pessimal stimulation is caused to the stomach by unprocessed kitasamycin which has the bitter taste can be avoided, meanwhile, it can be ensured that effective ingredients can completely and accurately reach the intestinal tract, the dissolution rate of intestinal drugs is improved, the concentration of the intestinal drugs and the drug effect intensity are greatly improved, and therefore the using performance of the kitasamycin is improved.
Owner:无锡华诺威动物保健品有限公司

New process for preparing meleumycin

The invention discloses a method for preparing meleumycin through fermentation of streptomyces mycarofaciens. The method comprises the following steps of: fermenting streptomyces mycarofaciens through a new fermenting base formula, to improve contents of medemycin A1 and kitasamycin back A6; after fermentation, through an extraction and a back extraction, extracting by a new mixing extracting agent, to improve extracting rate; and automatically crystallizing, to separate out the meleumycin. The process disclosed by the invention, which produces the meleumycin through a new fermenting base formula, simplifies meleumycin extraction process, and has characteristics of simple and convenient operation, energy conservation and the like; and the meleumycin produced by the process disclosed by the invention is accordant with related requirements of Chinese Pharmacopoeia 2010 version, and is applicable to industrial mass production.
Owner:贯虹科技有限公司

Clean kitasamycin extraction process

ActiveCN106188186AEmission reductionOvercoming technical bias in direct emissionsSugar derivativesSugar derivatives preparationWater basedFiltration
The invention belongs to an antibiotic production process and particularly relates to a clean kitasamycin extraction process. The clean kitasamycin extraction process comprises the steps of fermentation broth acidification, filtration, extraction, raffinate recovery and the like. In an existing production process, extracted raffinate is subjected to harmless treatment and then is always and directly discharged. According to the clean kitasamycin extraction process, it is considered that the main component of the raffinate is water based on relevant production technology study, the raffinate can be reused for the production process after being treated properly, the sewage treatment cost can be better reduced while water resources are saved in use, and accordingly production benefits are improved. The process overcomes the technical prejudice on direct discharge of production wastewater to some degree. Compared with existing production processes, the clean kitasamycin extraction process is lower in improvement cost and is simple. Due to the fact that the wastewater discharge proportion can be obviously reduced, the production cost can be reduced and the environmental protection benefits and production benefits are more remarkable, and the antibiotic production process has better practicability and a popularization and application value.
Owner:TOPFOND PHARMA CO LTD

Ultraviolet spectrophotometric detection method for kitasamycin content

Belonging to the technical field of kitasamycin content detection, the invention discloses an ultraviolet spectrophotometric detection method for kitasamycin content. The method includes preparation of a standard solution, determination of a regression equation, sample detection and other processes. The method has short detection time, the detection process can be restored, and the detection process only uses water as the solvent, therefore the method has the characteristics of green and environmental protection, safety and no toxicity.
Owner:JIANGSU WISE SCI & TECH DEV

Buffer liquid system and application thereof to extraction of kitasamycin

The invention belongs to the field of antibiotic medicaments, and provides a new buffer liquid system for extraction of kitasamycin. The buffer liquid system is solution mainly containing unitary or polybasic carboxylic acid having less than 10 carbon atoms and soluble salt thereof, wherein pH ranges from 1.5 to 4.2. The buffer liquid system can effectively solve the problem that a large amount of phosphorus element is brought into production to cause over high phosphorus content in waste water because phosphoric acid buffer liquid is generally used for back extraction of the kitasamycin in aconventional process. The system greatly increases the problem of pressure on environment-friendly treatment and can effectively prevent the phosphorus element from being brought into the production to relieve the pressure on environment-friendly dephosphorization.
Owner:浙江普洛生物科技有限公司 +1

Ureaplasma urealyticum/mycoplasma hominis combined rapid culture and drug sensitivity detection kit

Provided is a ureaplasma urealyticum/mycoplasma hominis combined rapid culture and drug sensitivity detection kit. The kit can complete detection in 8-24 h, and meanwhile, drug-resistant detection of various antibiotics can be performed. The combined rapid culture kit is mainly composed of pork stomach digestive juice or lung digestive juice, a beef extracting solution or a beef heart extracting solution, cattle serum or horse serum or other animal serum, sodium chloride, peptone, yeast powder, urea, L-arginine, phenol red indicator or cresol red indicator, and penicillin or other antibiotics. The drug detection kit can detect doxycycline hyclate, roxithromycin, acetylspiramycin, gatifloxacin, clarithromycin, azithromycin, clindamycin, erythromycin, kitasamycin, ofloxacin, levofloxacin hydrochloride, sparfloxacin, ciprofloxacin, doxycycline, erythromycin cydocarbonate and various other antibiotics. By means of the detection kit, not only is the mycoplasma detection time shortened, but also drug-resistant detection can be performed at the same time so that clinical medication can be guided. The detection kit has the beneficial effects of being high in sensitivity, high in specificity, high in detection rate, easy and convenient to operate and the like.
Owner:姜洪波 +1

Fermentation medium and fed batch method for improving fermentation level of meleumycin

The invention provides a fermentation medium for improving the fermentation level of meleummycin. The fermentation medium includes 1.5-3.0% of glucose, 2-5% of soybean powder, 0.1-0.3% of yeast powder, 0.1-0.5% of fish meal, 0.05-0.2% of potassium dihydrogen phosphate, 0.05-0.2% of magnesium sulfate and 1-10% of oil. The invention also provides a method for improving the fermentation level of meleomycin. The medium is used, Streptomyces mycarofaciens is used as a fermentation strain, and a glucose solution is added when the pH of a fermentation broth rebounds to 6.0 from the lowest point in order to improve the fermentation level of meleomycin and the proportion of kitasamycin. The method is simple and is easy to implement, and when the method is used for the fermentative production of meleummycin, the content of the meleummycin can reach 3400-4000 mg / L, the weight proportion of medemycin A1 is about 58.38-59.75%, and the weight proportion of kitasamycin A6 can reach 24.72-29.72%; andthe tank yield of meleomycin after fermentation is about 1.2 times more than that of a control group without a supplemental glucose solution, and the A6 component content is increased by about 25% ormore.
Owner:PEKING UNIV FOUNDER GRP CO LTD +2

Production method of enteric-coated kitasamycin for feed

The invention discloses a production method of enteric-coated kitasamycin for feed, which comprises the following process steps: step one, the preparation of drug-loaded pellets; step two, inner layer sustained-release coating of the drug-loaded pellets, which prolongs the release and acting time of kitasamycin; and steps three, outer layer enteric coating of the drug-loaded pellets, which ensures the release in succus entericus and small or no release in gastric juice. The method has the advantages that the kitasamycin is subjected to pellets pelletizing and 99 percent of the prepared granulums can pass through 24 meshes, so the dust is greatly reduced and the fluidity is increased; the coating of the inner layer sustained-release agent (HPMC) prolongs the release and acting time of the kitasamycin, reduces medication times and reduces the medication cost; and a layer of enteric substance, namely acrylic resin-III is sprayed and coated on the outer layer of particles. The substance protects the kitasamycin which is a weakly alkaline antibiotic from being damaged by gastroc acid in stomach, quickly disintegrates after entering enteric canal and releases the kitasamycin; and then the kitasamycin is absorbed by gastrointestinal mucosa into blood drug to play a role of restraining the reproduction of pathogenic microorganism and preventing diarrhea. Insoluble in the stomach, kitasamycin coating formulations have no pessimal stimulation on the stomach, and cannot result in regurgitation and vomiting. In addition, the sustained-release formulation, namely the kitasamycin prolongs the acting time so the medication times is reduced, the medication cost of farmers is reduced, and the economic benefit is improved.
Owner:WUXI ZHENGDA POULTRY

4% healthcare premix of middle pigs

The invention discloses a 4% healthcare premix of middle pigs, which relates to the technical field of animal feeds and is made from the following raw materials in parts by weight: 26 parts of middle pig multi-minerals, 1.5 parts of phytase, 2.5 parts of middle pig multi-vitamins, 2 parts of arsanilic acid, 1.3 part of kitasamycin, 2 parts of specific section enzyme, 2 parts of probiotics, 2 parts of organic chromium, 1.5 parts of a flavoring agent, 2 parts of a sweetening agent, 1 part of an antioxidant, 2.5 parts of red skin element, 28.8 parts of choline chloride, 14 parts of 98.5% lysine, 75 parts of calcium hydrophosphate, 45 parts of salt, 150 parts of rock flour, 108 parts of zeolite, 53.5 parts of a mixture of rice chaff and husk, 16 parts of mulberry leaf powder, 20 parts of sweet potato powder, 15 parts of sweet potato leaf powder, 20 parts of peanut shell powder, 10 parts of bean cake, 10 parts of rapeseed oil dreg cake, 15 parts of sesame oil dreg cake and 6 parts of traditional Chinese medicine additives. The premix provided by the invention contains the traditional Chinese medicine ingredients, so that the normal nutrition demand of the middle pigs is ensured, diseases can be prevented and cured, the immunity of the animals can be improved, and the growth of the animals can be promoted; no toxic and side effects are caused, no drug resistance is generated, the environment is not polluted, the body immunity can be increased, the effect is rapid, the cost is low and the advantages of popularization and application are provided.
Owner:ANHUI ZHUANGDA FEED
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products